Ninna Aggerholm-Pedersen

Aarhus University

Denmark

Research Interests

Explore related searches

Professors in Immunology

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (16)

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (13)

Desiree Dorleijn

Ghent University Hospital

BELGIUM

View details

Birgitte Sandfeld-Paulsen

Aarhus University

DENMARK

View details

Niels Junker

Chief Physician

DENMARK

View details

Robert Zachariae

Professor

Aarhus Universitet Business and Social Sciences

DENMARK

View details

Signe Borgquist

Aarhus University

DENMARK

View details

Estrid V. Hoegdall

University of Copenhagen

DENMARK

View details

Thomas Baad-Hansen

Aarhus University

DENMARK

View details

Luit Penninga

Clinical Associate Professor

University of Copenhagen

DENMARK

View details

Judith Bovee

professor of pathology

Leiden University

NETHERLANDS

View details

Anne Winther Larsen

Aarhus University

DENMARK

View details

Lise Bech Jellesmark Thorsen

VIP, Clinical Associate Professor

Aarhus University

DENMARK

View details

Malene Møller Jørgensen

Aalborg University

DENMARK

View details

Martin R. Jakobsen

DENMARK

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Ninna Aggerholm-Pedersen

Research Interests

Explore related searches

Contact this professor

Articles (16)

Changes in experienced quality of oncological cancer care during the COVID-19 pandemic based on patient reported outcomes - a cross-sectional study

The observational EURACAN prospective clinical registry dedicated to epithelioid hemangioendothelioma

A Retrospective Study of 291 Patients With Head and Neck Sarcomas: Treatment, Outcomes, and Prognostic Factors

Treatment of poorly differentiated neuroendocrine carcinomas of rectum and anus with chemoradiotherapy

Inclusion of Metabolic Tumor Volume in Prognostic Models of Bone and Soft Tissue Sarcoma Increases the Prognostic Value

Targeted Treatment of Soft-Tissue Sarcoma

Pretreatment platelet count is a prognostic marker in lung cancer:

Macrophage Biomarkers sCD163 and sSIRPα in Serum Predict Mortality in Sarcoma Patients

Local disease control after stereotactic body radiotherapy in patients with neuroendocrine neoplasms: a cohort study

Role of high‑sensitivity C‑reactive protein in patients with sarcoma

Analysis of circulating tumor DNA during checkpoint inhibition in metastatic melanoma using a tumor-agnostic panel

Validation of a novel risk score to predict early and late recurrence in solitary fibrous tumour

The Prognostic Value of Plasma Small Extracellular Vesicles' Phenotype in Patients With Gastrointestinal Stromal Tumor

The Prognostic Value of Plasma Programmed Death Protein-1 (PD-1) and Programmed Death-Ligand 1 (PD-L1) in Patients with Gastrointestinal Stromal Tumor

Pre-and Postoperative Circulating Tumour DNA in Patients With Gastrointestinal Stromal Tumour - A Methodological Assessment Study

Increased Soluble PD-1 Predicts Response to Nivolumab plus Ipilimumab in Melanoma

Collaborators (13)

Desiree Dorleijn

Birgitte Sandfeld-Paulsen

Niels Junker

Robert Zachariae

Signe Borgquist

Estrid V. Hoegdall

Thomas Baad-Hansen

Luit Penninga

Judith Bovee

Anne Winther Larsen

Lise Bech Jellesmark Thorsen

Malene Møller Jørgensen

Martin R. Jakobsen

Make your next move.